{
    "organizations": [],
    "uuid": "af710643bf90b6e69190223bb0e813bb20319b2e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-deciphera-pharma-initiates-late-st/brief-deciphera-pharma-initiates-late-stage-study-in-gastrointestinal-cancer-patients-idUSFWN1OZ0MD",
    "ord_in_thread": 0,
    "title": "BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 12:14 PM / Updated 8 minutes ago BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients Reuters Staff 1 Min Read \nJan 4 (Reuters) - Deciphera Pharmaceuticals Inc: \n* DECIPHERA PHARMACEUTICALS INITIATES PHASE 3 CLINICAL STUDY WITH DCC-2618 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (“INVICTUS” STUDY) \n* DECIPHERA PHARMACEUTICALS - EXPECT TO REPORT TOP-LINE RESULTS IN 2019 AND, IF SUCCESSFUL, THE PHASE 3 STUDY COULD SERVE AS BASIS FOR NDS Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T14:13:00.000+02:00",
    "crawled": "2018-01-04T14:36:22.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "initiate",
        "late",
        "stage",
        "study",
        "gastrointestinal",
        "cancer",
        "patient",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "deciphera",
        "pharmaceutical",
        "inc",
        "deciphera",
        "pharmaceutical",
        "initiate",
        "phase",
        "clinical",
        "study",
        "patient",
        "advanced",
        "gastrointestinal",
        "stromal",
        "tumor",
        "invictus",
        "study",
        "deciphera",
        "pharmaceutical",
        "expect",
        "report",
        "result",
        "successful",
        "phase",
        "study",
        "could",
        "serve",
        "basis",
        "nd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}